[1] |
Beyer DC, Puente F, Rogers KL, et al.
Prostate brachytherapy: comparison of dose distribution with different 125I source designs[J]. RadiologyRadiology, 2001, 221(3): 623-627.
doi: 10.1148/radiol.2213010130
|
[2] |
Ankem MK, De Carvalho VS, Harangozo AM, et al.
Implications of radioactive seed migration to the lungs after prostate brachytherapy[J]. UrologyUrology, 2002, 59(4): 555-559.
doi: 10.1016/S0090-4295(01)01660-0
|
[3] |
Raben A, Mychalczak B.
Brachytherapy for non-small cell lung cancer and selected neoplasms of the chest[J]. ChestChest, 1997, 112(4 Suppl): 276S-286S.
|
[4] |
柴树德, 郑广钧, 毛玉权, 等.
CT引导下经皮穿刺种植放射性125I粒子治疗晚期肺癌[J]. 中华放射肿瘤学杂志中华放射肿瘤学杂志, 2004, 13(4): 291-293.
doi: 10.3760/j.issn:1004-4221.2004.04.013
|
[5] |
车剑, 赵铁军.
125I籽源组织间植人治疗恶性肿瘤的疗效分析[J]. 中国现代医药杂志中国现代医药杂志, 2008, 10(8): 47-48.
|
[6] |
Finkelstein DM, Ettinger DS, Ruckdeschel JC.
Long-term survivors in metastatic non-small-cell lung cancer: an eastern cooperative oncology group study[J]. J Clin OncolJ Clin Oncol, 1986, 4(5): 702-709.
doi: 10.1200/JCO.1986.4.5.702
|